Evidence map›Paper›PMID 42090418›Full record

ArticlePLoS computational biology2026

scHG: A supercell framework with high-order graph learning enables scalable multi-omics analysis.

Yixiang Huang, Yuan Gan, Xinqi Gong

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yixiang HuangSchool of Mathematics, Renmin University of China, Beijing, China.
Yuan GanSchool of Mathematics, Renmin University of China, Beijing, China.
Xinqi GongSchool of Mathematics, Renmin University of China, Beijing, China.ORCID https://orcid.org/0000-0003-2802-6176

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multi-omics profiling-spanning proteomics, transcriptomics, and additional omics data types-is rapidly advancing, providing increasingly detailed maps of cellular identity and function. Yet, identifying rare cell populations while maintaining computational tractability remains a major challenge in large-scale multi-omics clustering. Here, we introduce the supercell paradigm, in which expression-coherent cells are grouped into intermediate units that preserve weak but biologically meaningful local structure across omics layers, thereby improving sensitivity to rare populations that are often masked at the conventional cluster level. Supercells are constructed using angle-aware similarity metrics and second-order co-occurrence neighbors, with impurity cells pruned by degree centrality. Building on this idea, we develop scHG, a high-order graph learning framework with an omics-weighted optimizer that adaptively balances contributions from gene expression, surface proteins, and chromatin accessibility while remaining scalable on large datasets through sparse matrix optimization and iterative graph refinement. Across six benchmark datasets (up to 30672 cells), scHG consistently outperforms state-of-the-art methods, improving mean ARI and NMI by 3.97% and 3.54%, respectively, while reducing runtime by 26.40%. Beyond overall clustering accuracy, scHG resolves fine-grained heterogeneity within conventionally defined T-cell populations and, importantly, uncovers rare populations-including dendritic-cell populations and NK-like B cells-that remain hidden under standard clustering pipelines. These results demonstrate that supercells provide not only an efficient intermediate representation for large-scale multi-omics integration, but also a practical mechanism for rare-cell detection.

Indexed as

Computational BiologyMultiomicsAlgorithmsAnimalsCluster AnalysisClustering AlgorithmsGene Expression ProfilingHumansMachine LearningProteomics

Identifiers

PMID42090418
PMCPMC13167035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.